The high-value segment driving the long-term In Vitro Diagnostics Market Outlook is Oncology, specifically through the accelerated adoption of Companion Diagnostics (CDx). The global effort in cancer screening, diagnosis, and treatment monitoring creates a perpetual demand for sophisticated IVD solutions. The oncology segment is particularly lucrative due to the complex, iterative nature of...